Neudle.com: TNF inhibitor

Differential
(Click to cross reference)

abciximab

abdominal reflex, absent

abortion, spontaneous

acetylcholine receptor

acetylcholine receptor antibody

acoustic neurinoma

acquired immunodeficiency syndrome

acyclovir

adalimumab

aducanumab

advances in neurology

adverse drug reaction

Alzheimer's disease, early onset

Alzheimer's disease, treatment of

amblyopia, toxic

AMPA receptor antibodies

amyloid

amyloid beta protein

amyloid beta protein antibodies

amyloid deposition

amyloid plaques

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

anemia

angiitis, granulomatous of CNS

angiotensin-converting enzyme

ankylosing spondylitis

anti GQ1b IgG antibody

anti JC virus antibodies

anti Yo antibody

anti-amyloid therapy

antineutrophil cytoplasmic autoantibodies

anxiety

aphasia

apolipoprotein E

apoliprotein E, plasma level

arachnoiditis

area postrema

area postrema syndrome

arteritides

arteritis, temporal

arteritis, temporal, recurrent

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune encephalopathy

autonomic dysfunction

azathioprine

B cell lymphocyte depletion

B cell lymphocytes

bacterial infection, CNS

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

behavioral disorder, acute

bone marrow transplantation

brachial plexus injury

brachial plexus neuropathy

brain atrophy

brain biopsy

brain biopsy, false negative

brain biopsy, negative

calcification, intracranial

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

cancer associated myopathy

cardiac surgery, neurologic complications with

cardiac transplantation

CAT scan, contrast enhanced, subepend.

CAT scan, emission, abnormal

catatonia

cauda equina

cauda equina, enhancement

cauda equina, lesion of

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellitis

cerebellitis, autoimmune

cerebellum, disease of

cerebral arteries

cerebral cortex

cerebral edema

cerebral edema, vasogenic

cerebral hypersensitivity, delayed

cerebral infarction, hemorrhagic

cerebral ischemia

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS tumors

cerebrospinal fluid, cytology

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, secondary prevention

cerebrovascular disease

chairbound

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

Clinical Pathologic Conference(C.P.C.)

cluster headache

cognition

coinfection

collapsin response mediator protein 5 IgG

comorbidities

complications

confusion

confusional state, acute

congenital malformation

congestive heart failure

contraindications

controversies in neurology

cop 1

corneal dystrophy

corpus callosum, lesion of

cost

cost effectiveness

cranial neuropathy

C-reactive protein, elevated

cytomegalovirus infection

dementia, rapidly progressive

dementia, reversible

dementia, treatment of

demyelinating disease

dentate nuclei

dentate nuclei, lesion of

dermatomyositis

developmental milestones, loss of

diabetes insipidus

diagnostic criteria

diarrhea

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

diurnal variation

dizziness

donanemab

DPPX, antibodies, encephalitis

drug abuse

drug holiday

drug induced neurologic disorders

drug withdrawal

dysarthria

dyskinesia

dyskinesia, buccal lingual facial

electroencephalogram, abnormalities of

electron microscopy

emotional lability

encephalitis

encephalitis, acanthamoeba

encephalitis, amebic

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, viral

encephalopathy

encephalopathy, anoxic

encephalopathy, delayed

eosinophilia

epidemiology of neurology

episodic disorders

epistaxis

Epstein-Barr virus

Epstein-Barr virus, negative

eptinezumab

erenumab

etanercept

evidence-based research

extralimbic encephalitis

eye movement, painful

face, numbness of

facial nerve palsy

facial nerve palsy, bilateral

facial pain

faciobrachial dystonic seizure

fluorescein angiography

fremanezumab

frexalimab

fumarate

fungal infection, CNS

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

glioblastoma multiforme(astrocytoma Gr.III)

glioma

glutamic acid decarboxylase, antibody

GM1 ganglioside antibodies

granulomatosis with polyangiitis

granulomatous disease

granulomatous hypophysitis

Guillain Barre syndrome

hallucination

hallucination, olfactory

headache

headache, children

headache, drug induced

headache, episodic

headache, preventive treatment

headache, prophylaxis

headache, recurrent

headache, severe

headache, treatment of

headache, unilateral

hearing loss

hemianopia

hemiplegia, progressive

hemoglobinuria

hemolysis

hemosiderosis of CNS, superficial

hepatic failure

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex virus infection, immunosuppressed patient

herpes zoster

hiccoughs

highly active antiretroviral therapy

hippocampus

HLA

Hodgkin's disease

human immunodeficiency virus type 1

hydrocephalus

hypercalcemia

hyperekplexia

hypereosinophilic syndrome(HES)

hypersensitivity reaction

hypertension

hypertrophic intracranial pachymeningitis

hypoglycorrhachia

hyponatremia

hypothalamus, lesion of

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

IgG4-related disease

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

inappropriate antidiuretic(A.D.H.)hormone

inborn errors of metabolism, screening

internal carotid artery

intracerebral hemorrhage

JC virus cerebellar granule cell neuronopathy

JC virus encephalopathy

lactic dehydrogenase(LDH)

laquinimod

lecanemab

leucine rich glioma inactivated 1 antibodies

leukoencephalopathy

leukoencephalopathy, toxic

levamisole

level of consciousness, decreased

life expectancy

limbic encephalitis

lipoprotein receptor-related protein 4

listeria monocytogenes

lymph node biopsy

lymphadenopathy

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

lymphomatoid granulomatosis

lymphopenia

mediastinum, lymph-node biopsy

mediastinum, mass of

medication withdrawal

medulla oblongata

medulla oblongata, lesion of

melanoma, malignant

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

meningitis

meningitis, aseptic

meningitis, bacterial

meningitis, basilar

meningitis, carcinomatous

meningitis, chronic

meningitis, drug induced

meningitis, iatrogenic

meningitis, listeria monocytogenes

meningitis, lymphomatous

meningitis, neutrophilic

meningitis, noninfectious

meningitis, pneumococcal

meningitis, recurrent

meningitis, TB

meningoencephalitis

meningoencephalopathy

meningomyelitis

mental status, abnormal

mercaptopurine

mesial temporal lobe

methotrexate

microhemorrhage, intracerebral

microscopic polyangiitis

microsporidia

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebral artery

migraine

migraine, children

migraine, chronic

migraine, intractable

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mild cognitive impairment

mimics

misdiagnosis

monoclonal antibodies

monoclonal antibodies for tumor cells in CSF

monoclonal gammopathy

mononeuropathy

mononeuropathy multiplex

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, magnetization transfer sequence

MRI, mass effect on

MRI, negative

MRI, nodular enhancement

MRI, spinal cord, increased intramedullary cord signal

MRS

multinucleated giant cell

multiple sclerosis

multiple sclerosis, children

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, etiology of

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, relapsing

multiple sclerosis, treatment of

muscle weakness, proximal

MuSK antibodies

mutism

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, drug induced

myasthenia gravis, drug resistant

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myelitis, longitudinal

myelitis, transverse

myelitis, transverse, recurrent

natalizumab, discontinuation

necrotizing vasculitis

negative

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-differential diagnosis

neoplasm, primary of CNS-recurrent

neoplasm, primary of CNS-survival

neoplasm, primary of CNS-treatment of

nerve biopsy

neurexin-3 alpha antibodies

neurofibromatosis 2

neurofilament light chain protein

neurologic complications

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neurolymphomatosis

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuronal cell surface antigen

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, vasculitic, systemic

nonsteroidal anti-inflammatory drug

nortriptyline

ocrelizumab

oculovestibular reflex

ofatumumab

old age, neurology of

ophelia syndrome

ophthalmoplegia

opisthotonus

opportunistic infection

opportunistic infection, CNS

optic chiasm

optic chiasm, lesion of

optic nerve, lesion of

optic neuritis

optic neuropathy

optic neuropathy, toxic

oral contraceptives

pain

pain, abdominal

paraneoplastic cerebellar degeneration

parasitic infection

parasitic infection, CNS

paresthesias

paroxysmal nocturnal hemoglobinuria

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

pituitary stalk, enlarged

plasmapheresis

plasmapheresis, complications of

platelet inhibiting drugs

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

pneumonia

polymerase chain reaction

polymerase chain reaction, false negative

polymyalgia rheumatica

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

pontine hemorrhage

posterior leukoencephalopathy syndrome

postoperative neurologic complications

postpartum

postural abnormality

potassium channel antibodies

practice guidelines

precipitating factors

preclinical

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protozoan infection

psoriasis

psoriatic arthritis

psychiatric problems in neurologic disorders

pulmonary infiltrates

quadriparesis

quality of life

race

radiation therapy, CNS treatment and complications with

radiation therapy, total body

rapidly fatal neurologic illness

rapidly progressing neurologic illness

remote effect of cancer on the nervous system

remternetug

renal transplantation

respiratory failure

review article

rheumatoid arthritis

rheumatoid arthritis, neurologic complications of

rimegepant

risk factors

risk stratification

risk-benefit assessment

sedimentation rate, elevated

seizure

seizure, focal

seizure, intractable

seizure, psychomotor-temporal lobe

serologic testing

serologic testing, false negative

seronegative

seropositive

serotonin agonist

shared decision making

shoulder, pain in

skin, lesions in neurologic disorders

sleep pathology and physiology

somnolence

speech disorder

speech disorder, childhood

spinal cord

spinal cord, lesion of

splenic-vein thrombosis

splenomegaly

stem cell transplantation

steroid

steroid sparing therapy

steroid therapy, CNS treatment and complications with

stiff joints

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

subarachnoid hemorrhage

temporal lobe, lesion

temporal lobe, lesion, bilateral

teratoma

teratoma, ovarian

thalamus, lesion of

thalamus, lesion of-bilateral

tissue plasminogen activator, intravenous

tocilizumab

toxoplasmosis, acquired

toxoplasmosis, CNS

TRAILBLAZER-ALZ trial

transient ischemic attack

treatment of neurologic disorder

treatment resistant

tremor

trigeminovascular system

triptans

tuberculosis

tumor necrosis factor

tumor necrosis factor inhibitor

uveitis

vaccination, neurologic complications with

vaccine

vagus nerve stimulation

varicella zoster virus

varicella zoster virus, encephalitis

varicella zoster virus, vasculopathy

vascular endothelial growth factor

vasculitides

vasculopathy

ventricular assist device

vomiting, intractable

walking, difficulty with

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

weight loss

white matter disease

white matter disease, subcortical

workup

zilucoplan

Showing articles 200 to 250 of 877 << Previous Next >>

Immunologic Responses of Progressive Multiple Sclerosis Patients Treated with an Anti-T-Cell Monoclonal Antibody
Neurol 36:777-784, Hafler,D.A.,et al, 1986

Use of Monoclonal Antibody Panel to Identify Malignant Cells in Cerebrospinal Fluid
Lancet 1:1095-1098, Coakham,H.B.,et al, 1984

Diagnostic Importance of Immunological Markers in Lymphoma Involving the Central Nervous System
Ann Neurol 16:668-672, Ezrin-Waters,C.,et al, 1984

Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025

Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025

Risk of Dementia After Initiation of Sodium-Glucose Cotransporter-2 Inhibitors Versus Dipeptidyl Peptidase-4 Inhibitors in Adults Aged 40-69 years with type 2 Diabetes:Population Based Cohort Study
BMJ doi:10.1136/BMJ-2024-07945, Shin,A., et al, 2024

Apixaban vs Aspirin in Patients with Cancer and Cryptogenic Stroke A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial
JAMA Neurol 81:957-965, Navi,B.B.,et al, 2024

SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
Neurol 103:e209805, Kim,H.K.,et al, 2024

Thrombolysis After Dabigatran Reversal for Acute Ischemic Stroke
Neurol 103:e209862, Theodorou,A.,et al, 2024

Optimal Timing of Anticoagulation after Acute Ischaemic Stroke with Atrial Fibrillation (OPTIMAS): A Multicentre, Blinded-Endpoint, Phase 4, Randomised Controlled Trial
Lancet 404:1731-1741, Werring,D.J.,et al, 2024

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
NEJM 390:1745-1755, 1815, Connolly,S.J.,et al, 2024

Mechanical Thrombectomy in Anticoagulated Patients with Acute Ischemic Stroke, A Meta-Analysis
Neurologist 29:194-203, Zhang,H.L.,et al, 2024

Vitamin B12 Deficiency:NICE Guideline Summary
BMJ 385:q1019, q1262, Sands,T.,et al, 2024

Advances in Cerebral Venous Thrombosis
Stroke 55:2169-2172, deSousa,D.A. & Neto,L.L., 2024

Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients with Atrial Cardiopathy, The ARCADIA Randomized Clinical Trial
JAMA 331:573-581, Kamel,H.,et al, 2024

Repurposing Erectile Dysfunction Medication for Alzheimer Disease Prevention
Neurol 102:e209180, Yasara,S., & Nidadavolu,L., 2024

Diagnosis and Management of Cerebral Venous Thrombosis:A Scientific Statement From the American Heart Association
Stroke 55:e77-e90, Saposnik,G.,et al, 2024

Progressive Hemiparesis and White Matter Abnormalities in an HIV-Negative Patient
Neurol 100:1156-1163, Jabbari,E.,et al, 2023

Intravenous Thrombolysis in Patients with Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
JAMA Neurol 80:233-243, 231, Meinel,T.R.,et al, 2023

Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Patients with Melanoma
Neurol 101:e2472-e2482, Pepys,J.,et al, 2023

Perioperative Management of Anticoagulant and Antiplatelet Therapy
NEJM Evid doi:10.1056/EVIDna2200322, Douketis,J.D. & Spyropoulos,A.C., 2023

In Patients with Melanoma Brain Metastases, is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised Topic
Neurologist 27:290-297, Gritsch, D.,et al, 2022

Progressive Vertebrobasilar Vasculopathy and Stroke Secondary to Giant Cell Arteritis
Stroke 53:e435-e438, Mahjoub, Y.,et al, 2022

Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects
JENDSO 6:1-7, Hamidi, S.,et al, 2022

Atypical Posterior Reversible Encephalopathy Syndrome Associated with Lenvatinib Therapy in a Patient with Metastatic Thyroid-Cancer
Cancer Reports doi:10.1002/cnr2.1605, Abhishek, M.,et al, 2022

A 48-Year-Old Woman with 6 Months of Vivid Visual Hallucinations
Neurol 99:166-171, Kizza, J.,et al, 2022

Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary
Neurol 98:31-43, Price, R.,et al, 2022

Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
Ann Neurol 91:78-88, Polymeris, A.A.,et al, 2022

Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory
Neurol 98:486-498, Turan, T.N.,et al, 2022

Idiopathic Intracranial Hypertension (Pseudotumor Cerebri): Prognosis and Treatment
www.UptoDate.com Mar, Wall, M. & Lee, A.G., 2022

Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors
Stroke 52:3121-3131, Grimaldi-Bensouda, L.,et al, 2021

Clinical Outcomes in Atrial Fibrillation Patients with a History of Cancer Treated with Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 52:3132-3141, Chan, Y.H.,et al, 2021

Left Ventricular Dysfunction Among Patients with Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin
JAMA Neurol 78:1454-1460, Merkler, A.E.,et al, 2021

Cranial Nerve Disorders Associated with Immune Checkpoint Inhibitors
Neurol 96:e866-e875, Vogrig, A.,et al, 2021

Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage
Stroke 52:1390-1397, Micieli, A.,et al, 2021

The Effects of Long-Term Medication Use in Alzheimer Disease
Neurol 96:e2247-e2250, Karceski, S., 2021

Administering Thrombolysis for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants
JAMA Neurol 78:515-518, Seiffge, D.J.,et al, 2021

Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions
Ann Neurol 89:1255-1256, Lambert, N.,et al, 2021

Cerebral Venous Thrombosis
NEJM 385:59-64, Ropper, A.H. & Kline, J.P., 2021

Encephalitis Induced by Immune Checkpoint Inhibitors
JAMA Neurol 78:864-873, Velasco, R.,et al, 2021

Steroid-Responsive Encephalitis in Coronavirus Disease 2019
Ann Neurol 88:423-427, Pilotto, A.,et al, 2020

Polymyalgia Rheumatica and Giant Cell Arteritis
JAMA 324:993-994, Buttgereit, F.,et al, 2020

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

Association of Innovations in Radiotherapy and Systemic Treatments with Clinical Outcomes in Patients with Melanoma Brain Metastasis From 2007 to 2016
JAMA doi:10.1001/JAMANETWORKOPEN.2020.8204, Brastianos, H.C.,et al, 2020

Distal Symmetric Polyneuropathy in 2020
JAMA 324:90-92, Callaghan, B.C.,et al, 2020

Sensory Ganglionopathy
NEJM 383:1657-1662, Amato, A.A. & Ropper, A.H., 2020

Burning Pain in the Legs
NEJM 383:e18, Sacks, C.A., 2020

Convexity Subarachnoid Hemorrhage Soon after Starting a Direct Oral Anticoagulant in 2 Patients with Acute Infarction
J Stroke Cerebrovasc Dis 29:105216, Jugita, Y.,et al, 2020

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

Showing articles 200 to 250 of 877 << Previous Next >>